Language:

Cancer statistics, 2022

CA: a cancer journal for clinicians, 2022-01, Vol.72 (1), p.7-33 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society ;2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2022 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21708 ;PMID: 35020204

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Cancer statistics, 2022
Author: Siegel, Rebecca L. ; Miller, Kimberly D. ; Fuchs, Hannah E. ; Jemal, Ahmedin
Subjects: American Cancer Society ; Breast cancer ; Breast Neoplasms - diagnosis ; Breast Neoplasms - epidemiology ; cancer cases ; Cancer screening ; cancer statistics ; death rates ; Early Detection of Cancer - statistics & numerical data ; Early Detection of Cancer - trends ; Epidemiology ; Female ; Humans ; Incidence ; Lung cancer ; Lung Neoplasms - diagnosis ; Lung Neoplasms - epidemiology ; Male ; Medical screening ; Mortality ; Neoplasm Staging ; Prostate cancer ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - epidemiology ; SEER Program - statistics & numerical data ; Statistics ; Survival Rate ; United States - epidemiology
Is Part Of: CA: a cancer journal for clinicians, 2022-01, Vol.72 (1), p.7-33
Description: Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes. Incidence data (through 2018) were collected by the Surveillance, Epidemiology, and End Results program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2019) were collected by the National Center for Health Statistics. In 2022, 1,918,030 new cancer cases and 609,360 cancer deaths are projected to occur in the United States, including approximately 350 deaths per day from lung cancer, the leading cause of cancer death. Incidence during 2014 through 2018 continued a slow increase for female breast cancer (by 0.5% annually) and remained stable for prostate cancer, despite a 4% to 6% annual increase for advanced disease since 2011. Consequently, the proportion of prostate cancer diagnosed at a distant stage increased from 3.9% to 8.2% over the past decade. In contrast, lung cancer incidence continued to decline steeply for advanced disease while rates for localized‐stage increased suddenly by 4.5% annually, contributing to gains both in the proportion of localized‐stage diagnoses (from 17% in 2004 to 28% in 2018) and 3‐year relative survival (from 21% to 31%). Mortality patterns reflect incidence trends, with declines accelerating for lung cancer, slowing for breast cancer, and stabilizing for prostate cancer. In summary, progress has stagnated for breast and prostate cancers but strengthened for lung cancer, coinciding with changes in medical practice related to cancer screening and/or treatment. More targeted cancer control interventions and investment in improved early detection and treatment would facilitate reductions in cancer mortality.
Publisher: United States: Wiley Subscription Services, Inc
Language: English
Identifier: ISSN: 0007-9235
EISSN: 1542-4863
DOI: 10.3322/caac.21708
PMID: 35020204
Source: Geneva Foundation Free Medical Journals at publisher websites
MEDLINE

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Cancer statistics, 2022

Searching Remote Databases, Please Wait